Teniposide
A DNA synthesis inhibitor.
General information
Teniposide on PubChem
COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)O[C@H]6[C@@H]([C@H]([C@H]7[C@H](O6)CO[C@H](O7)C8=CC=CS8)O)O
Supporting references
| Link | Tested on | Impact factor | Notes | Publication date |
|---|---|---|---|---|
|
Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design
3CLpro Small molecule In silico Screening |
in silico | 1.85 | Predicted to inhibit SARS-CoV-2 3C-like protease. |
Jul/31/2020 |
|
SARS-CoV-2 Mpro inhibitors: identification of anti-SARS-CoV-2 Mpro compounds from FDA approved drugs
3CLpro Small molecule In silico |
in silico | 3.22 | Predicted to inhibit the SARS-CoV-2 3C-like protease. |
Nov/05/2020 |
|
Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19
Small molecule In silico |
in silico | 8.99 | Computational modelling predicts that the drug interacts with SARS-CoV-2 infection-related signalling pathways. |
Apr/12/2021 |
